Check out your Company Bowl for anonymous work chats.
Inclusion drives innovation. We are proud to be recognized as a top-scoring company on the Disability Equality Index, and thank Disability:IN and American Association of People with Disabilities for recognizing us as a #BestPlacetoWork for Disability Inclusion. We are IN for #DisabilityInclusion!
Congratulations to our Switzerland colleagues on being named "the most active medium-sized company" at the recent B2Run Schweizer Firmenlauf. Our Basel team of runners completed a 6km course, showing fantastic dynamic range. We are delighted to see them prioritize their well-being in such a fun way.
Read who Fast Company nominated as the World's Most Innovative Company in 2021!
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Read more about Moderna's Phase 3 study!!! Very exciting day for Moderna and all of our employees who have been working so hard to get to this day!
CMV Parent, Farah sits down with Moderna's Drew Nathenshon to honor & remember her daughter Maddie who passed away due to complications associated with CMV 12 days after her birth. Watch our new #CMVvoices video here: https://buff.ly/3h7996Q #StopCMV
We are raising awareness about CMV and sharing our CMV voices. Listen to this video to learn more about Acantha's experience as a CMV Mom.
What is CMV? CMV is a common virus that many adults and children contract in their lifetime. Though mostly asymptomatic, it can be passed from a pregnant mother to her unborn child. CMV is the leading infectious cause of birth defects in the United States with approximately 25,000 newborns in the U.S> infected every year.1,2 https://www.modernatx.com/sites/default/files/styles/media_slide/public/media-slider/CMV%20Voices%20Acanthas%20Story.png?itok=Y7f24T_T https://www.modernatx.com/cytomegalovirus-cmv
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA (mRNA-1273)Against Novel Coronavirus
Check out this great interview with our CEO, Stephane Bancel and CNBC Mad Money's Jim Cramer.
